Variables | Nystatin group | Control group | p-value |
---|---|---|---|
(n = 47) | (n = 48) |  | |
Duration of stay in NICU, n (%) | |||
 Mean duration time, days, mean (± SD) | 9.8 (±14.9) | 13.6 (±15.5) | 0.23 |
  ≤ 7 days, n (%) | 8 (17.0) | 8 (16.7) | 0.16 |
  > 7 days, n (%) | 18 (38.3) | 27 (56.3) |  |
Use of peripheral venous access, n (%) | 47 (100) | 48 (100) | 1.00 |
 Duration of peripheral venous access (days) | 24 (6–42) | 28 (5–62) | 0.18 |
Use of central venous access, n (%) | 38 (80.9) | 37 (77.1) | 0.80 |
 Duration of central venous access (days) | 19 (0–42) | 19 (0–42) | 0.96 |
Use of orogastric tube, n (%) | 47 (100) | 47 (97.9) | 1.00 |
 Duration of orogastric tube (days) | 30 (8–42) | 30 (8–42) | 0.76 |
Use of endotracheal tube, n (%) | 10 (21.3) | 16 (33.3) | 0.19 |
 Duration of endotracheal tube (days) | 2.6 (0–21) | 4.29 (0–31) | 0.26 |
Use of antibiotic therapy, n (%) | 43 (91.5) | 46 (95.8) | 0.44 |
 Duration of antibiotic therapy (days) | 19 (0–42) | 21 (0–42) | 0.4 |
Use of aminophylline, n (%) | 28 (59.6) | 35 (72.9) | 0.17 |
 Duration (days) | 11 (1–42) | 13 (3–42) | 0.42 |
Use of steroid, n (%) | 3 (6.4) | 3 (6.3) | 0.65 |
 Duration (days) | 1 (0–12) | 1 (0–3) | 0.38 |
Use of parenteral nutrition, n (%) | 45 (95.7) | 47 (97.9) | 0.62 |
 Duration (days) | 21 (0–41) | 22 (0–42) | 0.53 |
 Duration of parenteral lipid (days) | 16 (0–40) | 19 (4–39) | 0.15 |